• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US. CORP PRECISE PRO RX OUS; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US. CORP PRECISE PRO RX OUS; STENT, CAROTID Back to Search Results
Model Number N/A
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/28/2023
Event Type  malfunction  
Manufacturer Narrative
As reported, the stent of a precise pro rx 8 mm x 40 mm self-expanding stent delivery system (ses) did not deploy.The sds was not removed from the patient with the stent still in place.When removed, the stent was released less than a segment but did not dislodge.The stent was then withdrawn into the delivery system.The device was being used for a carotid artery stenting (cas) procedure.The device was stored, prepped, and opened as per the instructions for use (ifu).There were no damages to the packaging or device prior to use in the patient.The device was not attempted to be deployed outside of the body.There was no difficulty removing the product from the packaging.The target vessel was calcified with mild tortuosity.There was no acute angle, no bifurcation, no cto, and 60% stenosis.The stent delivery system did not pass through any acute bends.A contralateral approach was used.The sds did not have to pass through a previously placed stent.The user maintain a fixed inner shaft position during deployment.There was no unusual force applied during deployment of the stent.There was no reported patient injury.The device was not returned for analysis.A product history record (phr) review of lot 18125520revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported stent delivery system- deployment difficulty- partial deployment, was not confirmed since the unit was not returned for analysis.According to the instructions for use (ifu) ¿advance the device over the guidewire and through the introducer to the target site.If resistance is met during delivery system introduction, the system should be withdrawn and another system used.If resistance is felt during retraction of the outer sheath do not force deployment.Carefully withdraw the stent system without deploying the stent.¿ neither the phr review nor the information available suggests that the reported event could be related to the manufacturing process of the unit.Therefore, no corrective or preventive actions will be taken.
 
Event Description
As reported, the stent of a precise pro rx 8 mm x 40 mm self-expanding stent delivery system (ses) did not deploy.The sds was not removed from the patient with the stent still in place.When removed, the stent was released less than a segment but did not dislodge.The stent was then withdrawn into the delivery system.There was no reported patient injury.The device was being used for a carotid artery stenting (cas) procedure.The device was stored, prepped, and opened as per the instructions for use (ifu).There were no damages to the packaging or device prior to use in the patient.The device was not attempted to be deployed outside of the body.There was no difficulty removing the product from the packaging.The target vessel was calcified with mild tortuosity.There was no acute angle, no bifurcation, no cto, and 60% stenosis.The stent delivery system did not pass through any acute bends.A contralateral approach was used.The sds did not have to pass through a previously placed stent.The user maintain a fixed inner shaft position during deployment.There was no unusual force applied during deployment of the stent.The device was not returned for evaluation as was initially expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX OUS
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS US. CORP
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 32574
MX   32574
7863138372
MDR Report Key17378491
MDR Text Key319974222
Report Number9616099-2023-06556
Device Sequence Number1
Product Code NIM
UDI-Device Identifier20705032062425
UDI-Public(01)20705032062425(17)240630(10)18125520
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/24/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberPC0840XCE
Device Lot Number18125520
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CORDIS VASCULAR SHEATH
Patient Age58 YR
Patient SexFemale
Patient Weight72 KG
-
-